US2008038299A1PendingUtilityA1

Skincare Compositions Comprising Salicylic Acid

Assignee: RECKITT & COLMAN OVERSEASPriority: Feb 19, 2004Filed: Feb 19, 2005Published: Feb 14, 2008
Est. expiryFeb 19, 2024(expired)· nominal 20-yr term from priority
A61P 33/10A61P 31/10A61P 31/00A61P 29/00A61P 31/04A61P 31/12A61P 17/10A61K 8/042A61K 8/368A61K 8/64A61K 8/0208A61K 8/8158A61Q 19/00
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises alicylic acid or a salt thereof and hydrolysed milk protein. The composition is useful in the treatments of acne.

Claims

exact text as granted — not AI-modified
1 . A skincare composition with a pH in the range 2.5-6.0, suitable for topical application to the skin, the composition comprising 0.1-5% by weight salicylic acid or a salt thereof and hydrolysed milk protein, wherein the ratio of salicylic acid or salt thereof to hydrolysed milk protein is in the range from 2:1 to 15:1 parts by weight. 
   
   
       2 . A composition as claimed in  claim 1 , which comprises salicylic acid. 
   
   
       3 . A composition as claimed in  claim 2 , wherein the concentration of salicylic acid is at least 1% by weight. 
   
   
       4 . A composition as claimed in  claim 2 , wherein the concentration of salicylic acid is less than 3% by weight. 
   
   
       5 . A composition as claimed in  claim 2 , wherein the concentration of salicylic acid is in the range from 1% to 3% by weight. 
   
   
       6 . A composition as claimed in  claim 1 , wherein the concentration of hydrolysed milk protein is at least 0.05% by weight, and most preferably at least 0.1% by weight. 
   
   
       7 . A composition as claimed in  claim 1 , wherein the concentration of hydrolysed milk protein is less than 1% by weight. 
   
   
       8 . A composition as claimed in  claim 1 , wherein the concentration of hydrolysed milk protein is in the range from 0.1% to 1.0% by weight. 
   
   
       9 . A composition as claimed in  claim 1 , wherein the concentration of salicylic acid is in the range from 0.5 to 4% by weight, more preferably from 0.5 to 2% by weight and the concentration of hydrolysed milk protein is in the range from 0.08 to 2%, more preferably from 0.1% to 0.5% by weight. 
   
   
       10 . A composition as claimed in  claim 1 , wherein the ratio of salicylic acid or salt thereof to hydrolysed milk protein is in the range from 5:1 to 12:1 parts by weight. 
   
   
       11 . A composition as claimed in  claim 1 , wherein the pH is in the range from 2.5 to 4.0. 
   
   
       12 . A composition as claimed in  claim 1  further comprising one or more further topically active skincare agents selected from an anti-microbial or anti-bacterial compound, an anti-viral compound, an anti-fungal compound, an anti-inflammatory compound and an anthelmintic compound. 
   
   
       13 . A composition as claimed in  claim 12  wherein the anti-bacterial agent is a peroxide anti-bacterial agent. 
   
   
       14 . A composition as claimed in  claim 1 , which has the form of an aqueous or oily solution or dispersion or emulsion or a gel. 
   
   
       15 . A composition as claimed in  claim 14 , which is in the form of an emulsion. 
   
   
       16 . A composition as claimed in  claim 15 , wherein the emulsion is an oil-in-water emulsion. 
   
   
       17 . A composition as claimed in  claim 15 , wherein the emulsion is a water-in-oil emulsion. 
   
   
       18 . A composition as claimed in  claim 14 , which is in the form of an aqueous gel. 
   
   
       19 . A composition as claimed in  claim 1 , which further comprises a gelling and/or a thickening agent. 
   
   
       20 . A composition as claimed in  claim 19 , wherein the gelling agent is a copolymer of acryloyl dimethyl tauric acid or a salt thereof. 
   
   
       21 . A composition as claimed in  claim 1 , which comprises an aqueous solvent system. 
   
   
       22 . A composition as claimed in  claim 21 , wherein the solvent system is a mixed solvent system comprising water in admixture with a co-solvent. 
   
   
       23 . A composition as claimed in  claim 22 , wherein the co-solvent is an alcohol. 
   
   
       24 . A composition as claimed in  claim 1 , which comprises one or more excipients selected from the group consisting of emulsifiers, emollients, lipids, humectants or moisturisers, binders, conditioning agents, emulsion stabilising salts, preservatives, chelating agents or sequestering agents, abrasives, pH adjusters, surfactants, perfumes and colourings. 
   
   
       25 . An article comprising a fibrous substrate impregnated with a skincare composition with a pH in the range 2.5-6.0, suitable for topical application to the skin, the composition comprising 0.1% -5% by weight salicylic acid or a salt thereof and hydrolysed milk protein, wherein the ratio of salicylic acid or salt thereof to hydrolysed milk protein is in the range from 2:1 to 15:1 parts by weight. 
   
   
       26 . An article as claimed in  claim 25 , wherein the fibrous material is impregnated with the skincare composition in an amount in the range from 10 to 30% by weight, preferably from 15 to 25% by weight and most preferably from 18 to 22% by weight of the fibrous material. 
   
   
       27 . An article as claimed in  claim 25  comprising cellulose or cotton fibres or a mixture thereof. 
   
   
       28 . A method for the prophylactic or remedial treatment of acne, which method comprises the topical application to the skin of a patient of a skincare composition with a pH in the range 2.5-6.0, suitable for topical application to the skin, the composition comprising 0.1-5% by weight salicylic acid or a salt thereof and hydrolysed milk protein, wherein the ratio of salicylic acid or salt thereof to hydrolysed milk protein is in the range from 2:1 to 15:1 parts by weight. 
   
   
       29 . A method as claimed in  claim 28 , which is a cosmetic method. 
   
   
       30 . A method as claimed in  claim 28 , which is a therapeutic method. 
   
   
       31 . (canceled) 
   
   
       32 . (canceled)

Join the waitlist — get patent alerts

Track US2008038299A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.